shadow_tr
spacer
people
spacer

 

     

Paul Kieran Whelton, MD
Department of Epidemiology
Tulane University School of Public Health and Tropical Medicine
1440 Canal Street, Suite 2018
New Orleans, LA 70112
Phone: (504) 988-6580
Fax: (504) 988-1568   

pwhelton@tulane.edu
 


Research Interests:

Cardiovascular disease and renal disease epidemiology, prevention, treatment trials, policy, and global health.

 

Professional Achievements:

  • Milbank Scholar in Epidemiology (Career Development Award for Clinical Epidemiology Training), 1979 - 1984.
  • Fellow, American College of Clinical Pharmacology, 1985.
  • Tenth Annual Master Lecturer, St. Catherine Hospital, Chicago, 1987.
  • Fellow, Royal Academy of Medicine in Ireland (Epidemiology Section), 1989.
  • Delta Omega Honorary Public Health Society - Alpha Chapter, 1989.
  • Fellow, Royal College of Physicians of Ireland (Faculty of Public Health Medicine), 1991.
  • Honorary member, Chilean Society of Hypertension, 1991.
  • Dean’s Lecture, Johns Hopkins University School of Hygiene and Public Health, 1992.
  • Fellow, American Heart Association, Council on Epidemiology and Prevention, 1992.
  • Dean’s Lecture, Johns Hopkins University School of Hygiene and Public Health, 1993.
  • Director, Wade Hampton Frost Society for the Quantitative Sciences, Johns Hopkins University School of Hygiene and Public Health, 1994 - 1996.
  • Fellow, American College of Epidemiology, 1995.
  • Professor (Honorary), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China, 1995.
  • Interurban Club (Elected Member), 1996.
  • Visiting Professor, University of Auckland, Auckland, New Zealand, 1997.
  • Wade Hampton Frost Lecturer, Johns Hopkins University School of Hygiene and Public Health, 1997.
  • AOA Lecturer, Tulane University School of Medicine, 1997.
  • Professor (Honorary), Beijing Medical University School of Public Health, Beijing, China, 1997.
  • Fellow, American Heart Association, Council for High Blood Pressure Research, 1997.
  • Hiroshima University Medal, Hiroshima University School of Medicine, Hiroshima, Japan, 1997.
  • Professor Kazue McClaren Leadership Achievement Award, Asia-Pacific Academic Consortium for Public Health, 1998.
  • Visiting Professor, Department of Epidemiology and Public Health, National University of Ireland, University College Cork, Cork, Ireland, 1999.
  • Hoechest Marion Roussel Excellence in Leadership Award - COSEHC, 1999.
  • Whelton Conference Room and dedication Whelton portrait unveiling, Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions,                         Baltimore, Maryland, 2000.
  • Henderson Chair, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, 2000.
  • Johns Hopkins Society of Scholars (Elected member), Induction Ceremony, May 22, 2003,     Baltimore, Maryland, 2003.
  • Distinguished Alumnus Award, National University of Ireland, University College Cork, Faculty of Medicine and Health, 2003.
  • Presidential Award for outstanding contributions to the field of hypertension, American Society of Hypertension, Gulf Central Regional Chapter, New Orleans, Louisiana, 2004.
  • Honorary Professor, Soochow University, Suzhou, China, 2005.
  • Award for “heroic efforts, outstanding accomplishments, and immense compassion in response to the catastrophic events surrounding Hurricane Katrina,” Association of Academic Health Centers, 2005.
  • United States Department of Veterans Affairs, Medal for Leadership – Post Hurricane Katrina, 2005.
  • Senior Leadership Katrina Recognition Award: Survival, Recovery, Renewal, Tulane University, New Orleans, Louisiana, 2006.
  • Golden Wings Award, for contributions to research in nephrology, V International Conference on     Hypertension and the Kidney, Sponsored by the Spanish Society of Nephrology,                            Madrid, Spain, 2006.
  • “Paul Whelton: Rebuilding Tulane after Hurricane Katrina,” Profile published in The Lancet. 2006;367:643
  • Visiting Professor, University of Hong Kong, Hong Kong, February, 2007.
  • American Heart Association Population Research Prize (awarded by Daniel Jones, MD, President, AHA  at opening ceremony for AHA 2007 Scientific Sessions, Orlando, Florida, November 2007).
  • Hungarian Society of Hypertension, Award of Honorary Membership, Budapest, December, 2009.


Educational Background:

  • M.B., B.Ch., B.A.O. (undergraduate degrees facilitating licensing to practice medicine) Honors, Surgery, National University of Ireland, University College Cork, Ireland, 1970.
  • M.D. Research related to prevention and epidemiology of cardiovascular and renal disease, University College Cork, Ireland, 2003.
  • M. Sc. - Clinical Epidemiology, University of London, London, 1981.

 

Selected Publications (from >400):


Whelton PK, Goldblatt P. An investigation of the relationship between stomach cancer and cerebrovascular disease:Evidence for and against the salt hypothesis. Am J Epidemiol. 1982;115:418-427.

Whelton PK, Brennan PJ, Greenberg G, Miall WE, Raftery EB, Subramanian B, for the Medical Research Council (MRC) Working Party on Mild to Moderate Hypertension. Ventricular extrasystoles during thiazide treatment: Sub-study of MRC Mild Hypertension Trial. BMJ.1983;287:1249-1253.

Whelton PK, Hebert PR, Cutler J, Applegate WB, Borhani NO, Eberline K, Hammel S, Hollis J, Keough ME, Klag MJ, Oberman A. Baseline characteristics of participants in phase I of the Trials of Hypertension Prevention (TOHP). Ann Epidemiol. 1992;2:295-310.

Working Group on Primary Prevention of Hypertension (Whelton PK, Chair and lead author). Report of the National High Blood Pressure Education Program Working Group on Primary Prevention of Hypertension. Arch Intern Med. 1993;153:186-208.

Perneger TV, Klag MJ, Feldman HI, Whelton PK. Projections of hypertension-related renal disease middle-aged residents of the United States. JAMA. 1993;269:1272-1277.

Whelton PK. Epidemiology of hypertension. Lancet. 1994;344:101-106.

Perneger TV, Brancati FL, Whelton PK, Klag MJ. End-stage renal disease attributable to diabetes mellitus. Ann Intern Med. 1994;121:912-918.

Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and non-steroidal anti-inflammatory drugs. New Engl J Med. 1994;331:1675-1679.

Burt V, Whelton P, Roccella EJ, Brown C, Cutler J, Higgins M, Horan M, Labarthe D. Prevalence of hypertension in the U.S. adult population:Results from the Third National Health and Nutrition Examination Survey, 1988-1991.Hypertension. 1995;25:305-313.

Whelton PK, Buring JE, Borhani NO, Cohen JD, Cook N, Cutler JA, Kiley JE, Kuller LH, Satterfield S, Sacks F, Taylor JO, for the TOHP Collaborative Research Group. The effect of potassium supplementation in persons with a high normal blood pressure:Results from phase I of the Trials of Hypertension Prevention (TOHP).Ann Epidemiol. 1995;5:85-89.

Ibrahim MM, Rizk H, Appel LJ, Aroussy WE, Helmy S, Sharaf Y, Ashour Z, Kandil H, Roccella EJ, Whelton PK, for the NHP Investigative Team. Hypertension prevalence, awareness, treatment and control in Egypt: Results from the Egyptian National Hypertension Project (NHP). Hypertension. 1995;26:886-890.

Sacks FM, Brown LE, Appel L, Borhani NO, Evans D, Whelton P. Combinations of potassium, calcium, and magnesium on blood pressure in mild or borderline hypertension. Hypertension. 1995;26:950-956.

Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J. Blood pressure and end-stage renal disease in men. New Engl J Med. 1996;334:13-18.

Brancati FL, Appel LJ, Seidler AJ, Whelton PK. Effect of potassium supplementation on blood pressure in African Americans on a low potassium diet: A randomized, double-blind, placebo-controlled trial.Arch Intern Med. 1996;156:61-67.

Whelton PK, Williamson JD, Louis GT, Davis B, Cutler J. Experimental approaches to determining the choice of first-step therapy for patients with hypertension. The ALLHAT Research Group Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Clin Exper Hypertens. 1996;18:569-579.

Whelton PK, Lee JY, Kusek JW, Charlston J, DeBruge J, Douglas M, Faulkner M, Greene PG, Jones C, Kiefer S, Kirk KA, Levell B, Norris K, Peng S, Powers SN, Retta TM, Smith DE, Ward H, for the AASK Pilot Study Investigators. Recruitment experience in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials. 1996;16:17S-33S.

Whelton PK, Bahnson J, Appel LJ, Charleston J, Cosgrove N, Espland MA, Folmar S, Hoagland D, Krieger S, Lacy C, Lichterman L, Oats-Williams F, Tayback M, Wilson AC. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). J Am Geriatr Soc. 1997;45:185-193.

Whelton PK, Kumanyika SK, Cook NR, Cutler JA, Borhani NO, Hennekens CH, Kuller LH, Langford H, Jones DW, Satterfield S, Lasser NL, and Cohen JD, for the Trials of Hypertension Prevention Collaborative Research Group. Efficacy of non-pharmacologic intervention in adults with high normal blood pressure:Results from phase I of the Trials of Hypertension Prevention (TOHP). Am J Clin Nutr. 1997;65:652S-660S.

The Trials of Hypertension Prevention Collaborative Research Group (Whelton PK, Study Chair and Writing Group Member). The effect of weight loss and sodium reduction on blood pressure and hypertension incidence in overweight non-hypertensive persons: Final results of the Trials of Hypertension Prevention,phase II. Arch Intern Med. 1997;157:657-667.

Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ. The effects of oral potassium on blood pressure: A quantitative overview of randomized, controlled clinical trials. JAMA. 1997;277:1624-1632.

Klag MJ, Whelton PK, Randall BL, Neaton JD, Stamler J. End-stage renal disease in African-American and white men: 16-year MRFIT findings. JAMA. 1997;277;1293-1298.

Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ. Risk of end-stage renal disease risk in diabetes mellitus: A prospective cohort study of men screened for MRFIT. JAMA. 1997;278:2069-2074.

Whelton PK, Appel LA , Espeland MA, Applegate WB, Ettinger WH, Kostis JB, Kumanyika S, Lacy CR, Johnson KC, Folmar S and Cutler JA, for the TONE Collaborative Research Group. Sodium reduction and weight loss in the treatment of hypertension in older persons: A randomized, controlled trial of non-pharmacologic interventions in the elderly (TONE). JAMA. 1998;279:839-846.

He J, Klag MJ, Appel LJ, Charleston J, Whelton PK. Seven year incidence of hypertension in a cohort of middle-aged African-Americans and whites. Hypertension. 1998;31:1130-1135.

He J, Whelton PK, Bryan V, Klag MJ. Aspirin and risk of hemorrhagic stroke: Meta-analysis of randomized controlled clinical trials. JAMA. 1998;280:1930-1935.

He J, Vupputuri S, Allen K, Prehost MR, Hughes J, Whelton PK. Passive smoking and risk of coronary heart disease: A meta-analysis of epidemiologic studies. N Engl J Med. 1999;340:920-926.

He J, Klag MJ, Caballero B, Appel LJ, Charleston J, Whelton PK. Plasma insulin levels and incidence of hypertension in African-Americans and whites. Arch Intern Med. 1999;159:498-503.

Espeland MA, Whelton PK, Kostis JB, Bahnson JL, Ettinger WH, Cutler JA, Appel LA, Kumanyika S, Farmer D, Elam J, Wilson AC, Appelgate WB. Predictors and mediators of successful long-term withdrawal from antihypertensive medications. TONE Cooperative Research Group. Trial of Nonpharmacologic Interventions in the Elderly. Arch Fam Med. 1999;8:228-236.

He J, Ogden L, Vupputuri S, Lora C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular diseases in overweight U.S. men and women. JAMA. 1999;282:2027-2034.

Perneger TV, Whelton PK, Puddey IB, Klag MJ. Risk of end-stage renal disease associated with alcohol consumption. Am J Epidemiol.1999;150:1275-1281.

Ogden LG, He J, Lydick E, Whelton PK. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC-VI risk stratification. Hypertension. 2000;35:539-543.

He J, Whelton PK, Appel LA, Charleston J, Klag MJ. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension. 2000;35:544-549.

The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group Major cardiovascular events in hypertensive patients randomized to doxazosin versus chlorthalidone. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2000;283:1967-1975.

Stamler J, Appel L, Cooper R, Denton D, Dyer AR, Elliott P, Greenland P, Kesteloot H, Kumanyika S, Liu K, Marmot M, Van Horn L, Whelton P. Dietary sodium chloride (salt), other dietary components and blood pressure:Paradigm expansion, not paradigm shift. Acta Cardiologica. 2000;55:73-78.

Loria CM, Klag MJ, Caulfield LE, Whelton PK. Vitamin C status and mortality in U.S. adults. Am J Clin Nutr. 2000;72:139-145.

Bazzano LA, He J, Ogden LG, Loria C , Vupputuri S, Myers L, Whelton PK. Dietary potassium intake and risk of stroke in U.S. men and women: National Health and Nutrition Examination Survey I epidemiologic follow-up study. Stroke. 2001;32:1473-1480.

Gu D, He J, Wu X, Duan X, Whelton PK. Effect of potassium supplementation on blood pressure in Chinese: A randomized, placebo-controlled trial. J Hypertens. 2001;19:1325-1331.

Perneger TV, Klag MJ, Whelton PK. Recreational drug use: A neglected risk factor for end-stage renal disease. Am J Kidney Dis. 2001;38:49-56.

Bazzano LA, He J, Ogden LG, Loria C, Vupputuri S, Myers L, Whelton PK. Legume consumption and risk of coronary heart disease in U.S. men and women: NHANES I Epidemiologic Follow-up Study. Arch Intern Med. 2001;161:2573-2578.

Xin X, He J, Frontini M G, Ogden LG, Motsamai OI, Whelton PK. Effects of alcohol reduction on blood pressure: A meta-analysis of randomized controlled trials. Hypertension. 2001;38:1112-1117.

Ibrahim MM, Appel LJ, Rizk HH, Helmy S, Mosley J, Ashour Z, El-Aroussy A, Roccella EJ, Whelton P. Cardiovascular risk factors in normotensive and hypertensive Egyptians. J Hypertens. 2001;11:1933-1940.

He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Dietary sodium intake and incidence of congestive heart failure in overweight U.S. men and women: National Health and Nutrition Examination Survey Epidemiologic Follow-up Study (NHANES). Arch Intern Med. 2002;162:1619-1624.

Bazzano LA, He J, Ogden LG, Loria C, Vupputuri S, Myers L, Whelton PK. Agreement on nutrient intake between the databases of the First National Health and Nutrition Examination Survey and the ESHA Food Processor. Am J Epidemiol. 2002;156:78-85.

Bazzano LA, He J, Ogden LG, Loria C, Vupputuri S, Myers L, Whelton PK. Fruit and vegetable intake and risk of cardiovascular disease in U.S. adults: The first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Am J Clin Nutr. 2002;76:93-99.

The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-2997.

The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs. usual care. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA. 2002;288:2998-3007.

Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, Roccella EJ, Stout R, Vallbona C, Winston MC, Karimbakas J. The National High Blood Pressure Education Program Coordinating Committee. Primary prevention of hypertension: Clinical and public health advisory from the National High Blood Pressure Education Program. JAMA. 2002;288:1882-1888.

Bazzano LA, He J, Muntner P, Vupputuri S, Whelton PK. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the U.S. population. Ann Intern Med. 2003;138:891-897.

The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Diuretic versus α-blocker as first-step antihypertensive therapy. Final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension. 2003;42:239-246.

Bazzano LA, He J, Ogden LG, Loria CM, Whelton PK.Dietary fiber intake and reduced risk of coronary heart disease in U.S. men and women: The National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med. 2003;163:1897-1904.

Gu DF, He J, Wu XG, Reynolds K, Gan WQ, Liu DH, Su SY, Duan XF, Huang GY, Whelton PK. Prevalence, awareness, treatment and control of hypertension in China. 2003;37:84-89.

Muntner P, He J, Cutler JA, Wildman RP, Whelton PK. Trends in blood pressure among children and adolescents in the United States. JAMA. 2004;291:2107-2113.

Davis BR, Furberg CD, Wright JT, Cutler JA, Whelton P, for the ALLHAT Collaborative Research Group. ALLHAT: Setting the record straight. Ann Intern Med. 2004;141:39-46.

Muntner P, He J, Chen J, Fonseca V, Whelton PK. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: Analysis of the Third National Health and Nutrition Examination Survey (NHANES III). Ann Epidemiol. 2004;9:686-695.

Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet. 2005;365:217-223.

Cook NR, Kumanyika SK, Cutler JA, Whelton PK, for the Trials of Hypertension Prevention Collaborative Research Group. Dose-response of sodium excretion and blood pressure change among overweight,nonhypertensive adults in a 3-year dietary intervention study. J Hum Hypertens. 2005;19:47-54.

Whelton PK, Barzilay J, Cushman WC, Davis BR, Ilamathi E, Kostis JB, Leenen FHH, Louis GT, Margolis KL, Mathis DE, Moloo J, Nwachuku C, Panebianco D, Parish DC, Pressel S, Simmons DL, Thadani U, for the ALLHAT Collaborative Research Group. Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia. Arch Intern Med. 2005;165:1401-1409.

He J, Gu D, Wu X, Chen J, Duan X, Chen J, Whelton PK. Effect of soybean protein on blood pressure: A randomized, controlled trial. Ann Intern Med. 2005;143:1-9.

He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen C, Chen J, Wildman RP, Klag MJ, Whelton PK. Major causes of death among men and women in China. N Engl J Med. 2005;353:1124-1134.

Gu D, He J, Duan X, Reynolds K, Wu X, Chen J, Huang G, Chen C-S, Whelton PK. Body weight and mortality among men and women in China. JAMA. 2006;295:776-783.

Muntner P, DeSalvo KB, Wildman RP, Raggi P, He J, Whelton PK. Trends in the prevalence, awareness, treatment and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke. Am J Epidemiol. 2006;163:913-920.

Reynolds K, Gu D, Whelton PK, Wu X, Yan W, Mo J, He J. Prevalence and risk factors of overweight and obesity in China: The International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Obesity. 2007;15:10-18.

Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK. Long-term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the Trials of Hypertension Prevention (TOHP). BMJ. 2007;334:885-892.

He J, GU D, Chen J, Jaquish CE, Rao DC, Hixson JE, Chen J-C, Duan X, Huang J-F, Chen C-S, Kelly T-N, Bazzano L-A, Whelton PK for the GenSalt Collaborative Research Group. Gender difference in blood pressure responses to dietary sodium intervention in the GenSalt study. J Hypertens. 2009;27:48-54.

Cook NR, Obarzanek E, Cutler JA, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ and Whelton PK. Joint effects of sodium and potassium intake on subsequent cardiovascular disease: The Trials of Hypertension Prevention (TOHP) Follow-up Study. Arch Intern Med. 2009; 169: 32-40.

Muntner P, Krousel-Wood M, Hyre AD, Stanley E, Cushman WC, Cutler JA, Piller LB, Goforth GA, Whelton PK. Antihypertensive prescriptions for newly treated patients before and after the main antihypertensive and lipid-lowering treatment to prevent heart attack trial results and seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure guidelines. Hypertension. 2009; 53: 617-623.

Hu D, Sun L, Fu P, Xie J, Lu J, Zhou J, Yu D, Whelton PK. Prevalence and risk factors for type 2 diabetes mellitus in the Chinese adult population: the InterASIA Study. Diabetes Res Clin Pr. 2009; 84: 288-295.

Stafford R, Bartholomew K, Cushman W, Cutler J, Davis B, Dawson G, Einhorn P, Furberg C, Piller L, Pressel S, Whelton PK: ALLHAT Collaborative Research Group. Impact of the ALLHAT/JNC7 Dissemination Project on Thiazide-Type Diuretic Use. Arch Intern Med. 2010;170:851-858.

Gu D. Kelly TN. Hixson JE. Chen J. Liu D. Chen JC. Rao DC. Mu J. Ma J. Jaquish CE. Rice TK. Gu C. Hamm LL. Whelton PK. Genetic variants in the rennin-angiotensin-aldosterone system and salt sensitivity of blood pressure. J Hypertens. 2010; 28:1210-1220.

He J, Wofford MR, Reynolds K, Chen J, Chen CS, Myers L, Minor DL, Elmer PJ, Jones DW, Whelton PK. Effect of Dietary Protein Supplementation on Blood Pressure. A Randomized, Controlled Trial. Circulation. 2011;124:589-595.

Whelton PK. Urinary sodium and cardiovascular disease risk. Informing guidelines for sodium consumption. JAMA. 2011;306:2262-2264.

Krousel-Wood, Muntner P, Carson A, Anderson A, Delaune E, Cushman W, Cutler J, Piller L, Goforth G, Whelton PK. Hypertension control among newly treated patients before and after publication of the main ALLHAT results and JNC-7 guidelines.J Clinl Hypertens. 2012;14:277-283.

Whelton PK, Appel LJ, Socco RL, Anderson CA, Antman EM, Campbell N, Dunbar SB, Frohlich ED, Hall JE, Jessup M, Labarthe DR, MacGregor GA, Sacks FM, Stamler J, Vafiadis DK, Van Horn LV. Sodium, Blood Pressure and Cardiovascular Disease. Further Evidence Supporting the American Heart Association Sodium Reduction Recommendations. Circulation. 2012;126: 2880-2889.

Appel LJ, Whelton PK. Flawed evidence should not derail sound policy: the case remains strong for population-wide sodium reduction. Am J Hypertens. 2013;26:1183-1186.

Whelton PK, He J. The health effects of sodium and potassium in humans. Curr Opin Lipidol. (in press).

Cobb LK, Anderson CAM, Elliott P, Hu FB, Liu K, Neaton JD, Whelton PK, Woodward M, Appel LJ. Methodological issues in cohort studies that relate sodium intake and cardiovascular disease outcomes. Circulation. (in press).

Barzilay JI, Davis BR, Whelton PK. The glycemic effects of antihypertensive medications. Curr Hypertens Rep. (in press).



Personal Statement:

Born in Cork, Ireland and a medical school graduate (M.B., B.Ch., B.A.O.) of the National University of Ireland (University College Cork), Dr. Whelton also earned a master of science degree in epidemiology from the University of London, School of Hygiene and Tropical Medicine (M.Sc.) and an advanced research degree in medicine (M.D.) from the National University of Ireland, University College Cork. He received post-graduate training in internal medicine and nephrology at the Johns Hopkins Medical Institutions, and in epidemiology at the Medical Research Council Epidemiology and Medical Care Unit at Northwick Park Hospital (London).
 
Dr. Whelton spent 26 years in Baltimore, where he was professor of epidemiology at the Johns Hopkins School of Hygiene and Public Health, professor of medicine at the School of Medicine, director of the Outpatient General Clinical Research Center, and founding director of the Welch Center for Prevention, Epidemiology, and Clinical Research. In 1997 he moved to New Orleans as dean of the Tulane University School of Public Health and Tropical Medicine and in 1999 was appointed Senior Vice President for Health Sciences. He also served as dean of the School of Medicine at Tulane, president and chair of the Louisiana Gene Therapy Research Consortium, chair of the Louisiana Cancer Research Consortium, chair of the Louisiana Biomedical Research and Development Park Commission, and vice-chair of the New Orleans BioInnovation Center. In 2007 he moved to Chicago as President and CEO of the Loyola University Health System and Medical Center and concurrently served as Senior Vice President for Health Sciences at Loyola University Chicago where he was professor of preventive medicine and epidemiology at the Stritch School of Medicine. In 2011 he returned to New Orleans where he serves as the Show Chwan Health System Endowed Chair in Global Public Health at the Tulane University School of Public Health and Tropical Medicine.

Dr. Whelton has played a leadership role in many large NIH funded observational studies and clinical trials.  Currently, he serves as national chair of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) and the Systolic Blood Pressure Intervention Trial (SPRINT). He is a member of the Johns Hopkins Society of Scholars, a recipient of the Distinguished Alumnus Award from University College Cork/National University of Ireland and the American Heart Association Population Research Prize, and a past member of the National Heart, Lung, and Blood Institute Advisory Council.

[ View all Epidemiology Faculty ]

 

 
spacer

Department of Epidemiology, 1440 Canal Street, Suite 2000, New Orleans, LA 70112, 504-988-6809 tcarter1@tulane.edu